Regulations and Compliance for Cosmetics

I will present the various options that the Commission is considering for the targeted revision of the EU’s Cosmetics Regulation. These options include measures to address the risks from chemicals that could affect the endocrine system, a possible new definition of nanomaterials, digital labelling and the future of the SCCS.

• Are there any gains and losses?
• Who is the most impacted?

It is well known that there are meetings with the Competent Authorities and the European Commission about cosmetic products, but it is not the only place. Competent authorities from the Council of Europe (46 member states) meet at the Committee for Cosmetics and Consumer Health (CD-P-COS). They identify emerging risks, define priorities, write documents, make proposals for resolution and improve the cooperation between MS for market surveillance in the field of cosmetic products and tattoos. They also developed a network of Official Cosmetics Control Laboratories (OCCL): they developed analytical methods, foster co-operation among MS, promote technical collaboration and work towards mutual recognition of test results. The CD-P-COS holds joint sessions with the OCCL Network (MS + non-European observers) with the aim of optimising surveillance and pooling analytical resources and expertise across Europe.

In this presentation, CTPA provides an overview of the legal requirements and regulatory structure under the UK Cosmetics Regulation, including the practical implications of roles and responsibilities across the cosmetic supply chain and the future policies of the UK as a standalone country.  The session will:

• Give clarity on roles and responsibilities across the cosmetic supply chain.
• Highlight differences between the UK and EU regulations.
• Provide a detailed analysis of specific articles including labelling and claims.
• Explore opportunities for UK compliance.
• Review a horizon scan of upcoming regulatory implications.

This session will be helpful to anyone involved in development, compliance and supply of cosmetic products, or anyone looking to gain a thorough knowledge of the future of the UK regulations.

• GB CLP, UK Cosmetics Regulation, UK REACH
• Allowed / Not allowed ingredients + divergence
• Safety Assessment report
• Focus on UK REACH

This session will provide attendees with an understanding of how cosmetic ingredients are regulated under the UK frameworks for chemicals, covering the GB Classification, Labelling and Packaging (CLP) Regulation, the UK Cosmetics Regulation and UK REACH.  In particular, the presentation will cover the key regulatory processes relevant for cosmetic ingredients and how these different legislations interact and complement each other.   It is important to highlight that some of the regulatory process under UK legislation are still being finalised. 

Of major importance is also the divergence that cosmetic ingredients are seeing between the EU and UK chemical frameworks and how this is impacting industry now and in the future.  There are ways to track this, prepare accordingly and minimise difficult consequences as much as possible.

The EU regulatory framework on cosmetic products is constantly updated in light of the most recent scientific findings. The changes mostly concern ingredients: every year, several new substances are banned or restricted, and beauty brands must quickly adapt to the updates to ensure their cosmetic products remain compliant with the EU requirements.

For beauty brands, those changes may require a reformulation of their products which is a costly and time-consuming operation. Therefore, it is essential to be informed about news on substances and act promptly. Timely communication about ingredient updates by regulatory affairs professionals avoids business disruptions.

The presentation provides an overview of the substances that have been recently banned or restricted for use in cosmetic products and those that are likely to be in the near future. In particular, it will be focused on the latest Omnibus Acts V and VI, which apply, respectively, as of December 17, 2022, and December 1, 2023.

Moreover, the presentation contains a section dedicated to where the changes come from (European Commission, Scientific Committee on Consumer Safety, CLP Regulation) and, consequently, the sources to monitor to be always up-to-date. The use of cosmetic ingredients is regulated in the Annexes to the EU Cosmetics Regulation — We clarify how to read them.

Finally, the presentation gives manufacturers of cosmetic products some valuable tips on how to deal with regulatory updates on ingredients.

In accordance with the European Strategy for Sustainability, France would like to promote an European initiative on the issue of packaging, in particular concerning the limitation of the use of plastics and better consumer information to encourage the packaging industry to innovate towards more environmentally friendly materials.
This position has involved France to implement a new law: the AGEC law, which will also has an impact on the cosmetics sector, with specificities notably on labeling. This mainly concerns the prohibition of environmental claims, but also labelling obligations in relation to the recyclability of packaging. The law also requires an obligation to inform the consumer about the presence of hazardous substances in the product or packaging.
All these specificities will be presented by Dr Stephane Pirnay, president of EXPERTOX, which can support you in particular for the regulatory evolutions of this type but also for the laboratory testings (PIF mandatory or quality control or judicial expertise) and for the safety assessments or evalutions of your products, raw materials and packagings.

The term “label” is defined in the FD&C Act and the FP&L Act. The definitions differ in that under the FD&C Act definition a label is “a display of written, printed or graphic matter upon the immediate container,” and under the FP&L Act definition “written, printed or graphic matter affixed to any consumer commodity or affixed to or appearing upon a package containing any consumer commodity.” One may say that the term “label” applies in the first instance to the information appearing directly on the immediate container and in the second instance to information attached to the immediate container and directly on or attached to the outer container if so packaged. But what are the requirements for the labeling in cosmetics according to the Cosmetics Regulation 1223/2009? Are these requirements met at each time someone markets a cosmetic? In which circumstances should a label be corrected and how far can someone go in respect to the claim used in a label for a cosmetic product? And as we live in the era of digitalization, how can digital labelling affect the requirements that already exist? How can we perform a smoother transition towards the implementation of the digital labelling in cosmetics?

• Do classic biometrics still answer market needs?
• How to substantiate the new claims?
• What are the challenges of today’s clinical studies?

The future of clinical studies may involve, in the future, from a less classical option to the use of other scientific areas for the evaluations. The use of technological options that go beyond biophysical measurements for the claim substantiation may be one of the options.

Combining the evaluation of cosmetic efficacy tests with the evaluation of parameters such as well-being, emotional aspects, lifestyle impact or even genetics may complement clinical studies and offer a more complete answer to the industry.

Today’s consumers are increasingly concerned with stress, anxiety, tiredness or fatigue and are looking for products in their skin routine that provide a more holistic overview for the individuals. Several scientific measures such as cortisol quantification, heart rate measurements or even the use of eye tracking or facial expressions assessments can be used for giving guidance and data for claim substantiation that are trend and answer to the consumer needs.

Consumers are looking to make more sustainable choices, and to obtain greater transparency about the substances used in products, their origin, sourcing, manufacturer, and social and environment impact. Traditional consumer interest in cosmetic product claims such as natural, organic, and vegan have increasingly expanded to encompass characteristics linked to environmental and social criteria. When considering support for claims, third-party certification according to private standards can strengthen the substantiation of such claims and offers a high level of assurance to the consumer and for comparative assertions.  NATRUE will outline the existing tools and initiatives under development and initiatives that are available to help orientate cosmetic producers and consumer alike.

• What is PAO?
• What is open jar?
• What are the exceptions from the rule?

• History
• Draft regulation and next step

This presentation will give an overview of the upcoming regulation on microplastics and the impacts for cosmetics manufacturers.

In recent years, accomplish a sustainable development has been a focus point of our society and consumer demands accompany this. In the cosmetic industry, we have been seeing a shift where products are more and more marketed with a “greener” approach, being formulated with natural or natural derived ingredients. However, a “greener” cosmetic formula can not only rely on using natural or natural derived ingredients but rather assess their sustainability, evaluating what is the environmental and social impact of the ingredients used.

The existence of several concepts that are marketing concepts and have not yet a legal definition, and the existence of different cosmetic standards lead to the emergence of greenwashed claims. Hopefully, several cosmetic companies and ingredient suppliers are committed to correctly promote green marketing.

In this communication is provided an overview of:

• What are “Greener” Cosmetic Formulas?
• Formulation challenges vs regulatory challenges